Drug · DIN 02563983
JERAYGO
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since December 24, 2025.
- Drug Identification Number (DIN)
- 02563983
- Company (DIN owner)
- Idorsia Pharmaceuticals LtdAllschwil, Basel-Landschaft, Switzerland
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Aprocitentan C02KN01
- Class
- Human
- Record last updated
- February 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| APROCITENTAN | 12.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 23, 2025: NOC 36630New Drug Submission (NDS)
Other DINs named JERAYGO
- DIN 02563991 · Approved